[go: up one dir, main page]

YU240690A - Fenil supstituisani derivati rodanina - Google Patents

Fenil supstituisani derivati rodanina

Info

Publication number
YU240690A
YU240690A YU240690A YU240690A YU240690A YU 240690 A YU240690 A YU 240690A YU 240690 A YU240690 A YU 240690A YU 240690 A YU240690 A YU 240690A YU 240690 A YU240690 A YU 240690A
Authority
YU
Yugoslavia
Prior art keywords
alkyl
hydrogen
c4alkyl
rodanine
derivatives
Prior art date
Application number
YU240690A
Other languages
English (en)
Inventor
Jaswant Singh Gidda
Jill Ann Panetta
Phillips Michael Leroy
Original Assignee
Eli Lilly And Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co. filed Critical Eli Lilly And Co.
Publication of YU240690A publication Critical patent/YU240690A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Surgical Instruments (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Eye Examination Apparatus (AREA)

Abstract

FENIL SUPSTITUISANI DERIVATI RODANINA. Ovaj pronalazak se odnosi na postupak za dobijanje jedinjenja koja leče zapaljenska oboljenja creva kod sisara. formula I gde su R1 i R2 svaki za sebe vodonik, C1-C6 alkil, C1-C6 alkoksi, C2-C6 alkenil, C2-C6 alkinil, C1-C4 alkil-O-C-(C1-C4alkil) ili gde je n vrednost od 0 do 3 obuhvatajući obe vrednosti; R3 je vodonik, ili C1-C6 alkil; R4 i R5 su vodonik ili grade vezu; R6 i R7 su vodonik ili =S, -OH ili -SCH3; X je gde je m 0,1 ili 2; 0 je -CH2- -O- ili NR8 gde je R8 vodonik, alkil, alkenil, cikloalkil, -SO2CH3 ili -(CH2)n-Y gde je n od 0 do 3, Y je cijano, OR9 , tetrazolil, -NR11R12, SH, -S(C1-C4 alkil) ili gde je R9 vodonik, C1-C4alkil, ili , R10 je C1-C4alkil, C1-C4 alkoksi, ili NH2, R11 i R12 su svaki za sebe vodonik, alkil, alkenil, alkinil, -(CH2)q-N(C1-C4alkil)2, -(CH2)qOH, -(CH2)q-S(C1-C4alkil, ili gde je n prethodno definisano a q je od 1 do 6; kada se R11 i R12 uzmu zajedno grade morfolinil, piperidinil, piperazinil, N-metilpiperazinil, ili njihove farmaceutski prihvatljive soli.
YU240690A 1989-12-21 1990-12-20 Fenil supstituisani derivati rodanina YU240690A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45420389A 1989-12-21 1989-12-21

Publications (1)

Publication Number Publication Date
YU240690A true YU240690A (sh) 1992-12-21

Family

ID=23803709

Family Applications (1)

Application Number Title Priority Date Filing Date
YU240690A YU240690A (sh) 1989-12-21 1990-12-20 Fenil supstituisani derivati rodanina

Country Status (22)

Country Link
EP (1) EP0434394B1 (sh)
JP (1) JP3036853B2 (sh)
KR (1) KR0176243B1 (sh)
CN (1) CN1029846C (sh)
AT (1) ATE169294T1 (sh)
AU (1) AU639734B2 (sh)
CA (1) CA2032330C (sh)
CY (1) CY2100B1 (sh)
DE (1) DE69032537T2 (sh)
DK (1) DK0434394T3 (sh)
ES (1) ES2121748T3 (sh)
FI (2) FI104251B1 (sh)
HU (1) HU216732B (sh)
IE (1) IE904633A1 (sh)
IL (3) IL108962A (sh)
MX (1) MX23803A (sh)
NO (1) NO300458B1 (sh)
NZ (1) NZ236472A (sh)
PT (1) PT96198B (sh)
RU (2) RU2036915C1 (sh)
YU (1) YU240690A (sh)
ZA (1) ZA9010041B (sh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87339A1 (fr) * 1988-09-20 1990-04-06 Oreal Nouveaux derives de benzylidene-cyclanones,leur procede de preparation,leur utilisation en tant qu'agents anti-oxydants et comme filtres solaires,compositions cosmetiques et pharmaceutiques les contenant
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
IL106877A (en) * 1992-09-10 1998-03-10 Lilly Co Eli Rodinin derivatives for use as drugs for the treatment of Alzheimer's disease
DE69301894T2 (de) * 1992-10-28 1996-11-07 Shionogi & Co Benzylidenderivate
US6251928B1 (en) 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
US5563277A (en) * 1994-12-21 1996-10-08 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
ES2153081T3 (es) * 1995-09-07 2001-02-16 Lilly Co Eli Forma cristalina alternativa de tazofelona((+,-)-5-((3,5-bis(1,1-dimetiletil)-4-hidroxifenil)metil)-4-tiazolidinona).
ATE193284T1 (de) * 1995-09-07 2000-06-15 Lilly Co Eli Verfahren zur herstellung von benzylsubstituierten rhodaninederivaten
EP0779282A1 (en) * 1995-12-14 1997-06-18 Eli Lilly And Company Thiomorpholinone compounds for treating multiple sclerosis
US5981523A (en) * 1996-02-05 1999-11-09 Eli Lilly And Company Compounds and methods for treating multiple sclerosis
US6063799A (en) * 1996-09-03 2000-05-16 Eli Lilly And Company Alternate crystal form of Tazofelone
US6005142A (en) 1996-09-03 1999-12-21 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
WO2000018748A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
WO2000018746A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
WO2000018747A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders
BR0314943A (pt) * 2002-09-30 2005-08-02 Univ California Inibidores da proteìna reguladora da condutância transmembrana da fibrose cìstica e usos destes
US7235573B2 (en) 2002-09-30 2007-06-26 The Regents Of The University Of California Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
AU2002953533A0 (en) * 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
JP5778755B2 (ja) * 2010-04-15 2015-09-16 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung ヒドロキノンの製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR862081B (en) * 1985-08-09 1986-12-24 Lilly Co Eli Di-t-butylphenol compounds
IE940525L (en) * 1988-05-25 1989-11-25 Warner Lambert Co Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents
CA2013599C (en) * 1989-04-07 1999-11-16 Jill A. Panetta Aryl-substituted rhodanine derivatives

Also Published As

Publication number Publication date
FI104251B (fi) 1999-12-15
NO905478D0 (no) 1990-12-19
AU639734B2 (en) 1993-08-05
IL96654A (en) 1995-06-29
FI906273L (fi) 1991-06-22
CY2100B1 (en) 2002-04-05
HU908368D0 (en) 1991-07-29
ZA9010041B (en) 1992-08-26
IL108962A0 (en) 1994-06-24
FI19991698L (fi) 1999-08-10
EP0434394B1 (en) 1998-08-05
CN1052668A (zh) 1991-07-03
KR910011812A (ko) 1991-08-07
NO300458B1 (no) 1997-06-02
PT96198A (pt) 1991-09-30
IE904633A1 (en) 1991-07-17
FI906273A0 (fi) 1990-12-19
MX23803A (es) 1994-02-28
IL108962A (en) 1996-12-05
CA2032330C (en) 2001-05-08
EP0434394A3 (en) 1992-01-08
HUT59915A (en) 1992-07-28
CN1029846C (zh) 1995-09-27
AU6826690A (en) 1991-06-27
FI104251B1 (fi) 1999-12-15
JPH04279573A (ja) 1992-10-05
EP0434394A2 (en) 1991-06-26
DE69032537T2 (de) 1999-01-21
RU2050355C1 (ru) 1995-12-20
DE69032537D1 (de) 1998-09-10
HU216732B (hu) 1999-08-30
ES2121748T3 (es) 1998-12-16
DK0434394T3 (da) 1998-12-14
PT96198B (pt) 1998-05-29
RU2036915C1 (ru) 1995-06-09
CA2032330A1 (en) 1991-06-22
KR0176243B1 (ko) 1999-03-20
NO905478L (no) 1991-06-24
ATE169294T1 (de) 1998-08-15
NZ236472A (en) 1993-03-26
JP3036853B2 (ja) 2000-04-24

Similar Documents

Publication Publication Date Title
YU240690A (sh) Fenil supstituisani derivati rodanina
YU101091A (sh) Heterociklična jedinjenja i njihovi derivati koji su modifikatori dejstva 5-hidroksitriptamina i postupak njihovog dobijanja
GB9524157D0 (en) Therapeutic agents
GR3014907T3 (en) Muscarinic receptor antagonists.
MY124864A (en) Adenosine a2a receptor antagonists
DE3460325D1 (en) N-phenyl-n'-cycloalkylalkanoylpiperazines and process for their preparation
YU48105B (sh) Derivati triazola i postupak za njihovo dobijanje
NZ511739A (en) New esters derived from substituted phenyl-cyclohexyl compounds
BR9611618A (pt) Composto processo para sua preparação composição farmacêutica e utilização de um compostos
MY109737A (en) Treatment and compounds.
NZ331457A (en) Methoxybenzophenone compounds, a process for their preparation and a method involving them for combating fungal growth
PL285683A1 (en) Method of obtaining novel amines
AR007108A1 (es) Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes.
PT96421A (pt) Processo para a preparacao de derivados de piperidina e de pirrolidina antagonistas de receptores muscarinicos
DK485489D0 (da) Amider og nitriler, framaceutiske praeparater indeholdende disse og anvendelse af forbindelserne til fremstilling af laegemidler
GB9812211D0 (en) Cinnamoyl distamycin analogous derivatives,process for their preparation,and their use as antitumor agents
HRP20000027B1 (en) Process for the preparation of alkoxyfuranoneamine derivatives, compounds obtained by this process, and the use of these compounds
GB9621795D0 (en) Pharmaceutical compounds
YU72392A (sh) Postupak za proizvodnju antihipertenzionog kombinacionog preparata
HUT50474A (en) Process for producing imidazobenzodiazepine derivatives and pharmaceutical compositions comprising such compounds as active ingredient
FI922342A (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-fenyyliglutarimidijohdannaisten valmistamiseksi
IL115085A (en) Piperazine bicyclic carboxamide derivatives their preparation and pharmaceutical compositions containing them
HUP0202057A2 (hu) 3-Fenil-3,7-diazabiciklo[3.3.1]nonán-vegyületek, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények
HUP0303691A2 (hu) Uretánszármazékok, eljárás az előállításukra és alkalmazásuk gyógyszerkészítmények előállítására